TABLE 4.
Sleep stages of the 14 patients analysed
| Placebo | Desipramine | p-value | |
|---|---|---|---|
| TST min | 266.0 (71.5) | 266.5 (124.0) | >0.5 |
| SE % | 60.4 (16.5) | 62.2 (15.4) | >0.5 |
| NREM1 %TST | 28.5 (14.7) | 34.0 (20.5) | 0.110 |
| NREM2 %TST | 51.0 (4.0) | 55.4 (17.2) | 0.058 |
| NREM3 %TST | 4.5 (13.1) | 0.9 (4.2) | 0.175 |
| REM %TST | 14.5 (10.9) | 2.0 (6.1) | 0.002 |
Data are presented as median (interquartile range), unless otherwise stated. TST: total sleep time; SE: sleep efficiency; NREM1, NREM2 and NREM3: non-rapid eye movement sleep stages 1, 2 and 3; REM: rapid eye movement sleep.